Breaking Through Synthesis Challenges: Hongene Accelerates Clinical Translation of Dual-Targeting Oligonucleotide Drugs!
NEWS On September 9, 2024, ReciBioPharm, a US-based contract development and manufacturing organization (CDMO) service provider, and Hongene Biotech, a leading supplier in the nucleic acid raw materials field, announced...